CABALETTA BIO, INC.

Insiders Cabaletta Bio, Inc.

Equities

CABA

US12674W1099

Market Closed - Nasdaq Other stock markets 21:00:00 15/05/2024 BST			5-day change	1st Jan Change
12.69 ^USD	+13.00%		+5.05%	-44.10%

03-22	HC Wainwright Adjusts Cabaletta Bio's Price Target to $30 From $25, Maintains Buy Rating	MT
03-21	Cabaletta Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cabaletta Bio Insider Sold Shares Worth $146,921, According to a Recent SEC Filing	20/10/23	MT
Insider Sell: Cabaletta Bio	22/08/23	MT
Cabaletta Bio, Inc. Appoints Shawn Tomasello to Its Board of Directors	24/07/23	CI
Insider Sell: Cabaletta Bio	21/06/23	MT
Cabaletta Bio, Inc. Announces Management Promotions	11/01/22	CI
Cabaletta Bio, Inc. Announces Executive Appointments	09/11/21	CI
Cabaletta Bio, Inc. Appoints Michael Gerard as General Counsel	07/09/21	CI
Cabaletta Bio, Inc. Announces Board and Committee Changes	28/06/21	CI
Carl June Joins Cabaletta Bio, Inc.’s Scientific Advisory Board	06/08/20	CI
Cabaletta Bio Appoints Brian Stalter as General Counsel	05/09/19	CI
Cabaletta Bio, Inc. Announces Appointment of David J. Chang, M.D., M.P.H., as Chief Medical Officer	15/07/19	CI
Cabaletta Bio Inc. Appoints Catherine Bollard to Its Board of Directors	02/04/19	CI
Cabaletta Bio Inc. Appoints Richard C. Henriques, Jr. to its Board of Directors	19/02/19	CI
Cabaletta Bio Appoints Anup Marda as Chief Financial Officer	23/01/19	CI
Cabaletta Bio Inc. Appoints Gwendolyn Binder as Executive Vice President, Science & Technology	12/12/18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

fermer